Financial results - PHARMA REGAL SRL

Financial Summary - Pharma Regal Srl
Unique identification code: 22058275
Registration number: J08/1834/2007
Nace: 4773
Sales - Ron
-
Net Profit - Ron
-3.554
Employees
Open Account
Company Pharma Regal Srl with Fiscal Code 22058275 recorded a turnover of 2024 of - , with a net profit of -3.554 and having an average number of employees of - . The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharma Regal Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 249.164 230.418 232.722 245.379 236.498 228.513 9.202 0 0 0
Total Income - EUR 255.926 234.575 237.796 249.426 237.723 277.711 9.583 59 1 1
Total Expenses - EUR 262.513 239.425 239.247 252.053 242.041 228.731 26.289 15.258 6.066 3.555
Gross Profit/Loss - EUR -6.587 -4.850 -1.452 -2.627 -4.318 48.980 -16.706 -15.199 -6.064 -3.554
Net Profit/Loss - EUR -6.587 -4.850 -3.623 -5.122 -6.695 46.379 -16.802 -15.201 -6.064 -3.554
Employees 4 4 4 3 3 3 1 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharma Regal Srl

Rating financiar

Financial Rating -
PHARMA REGAL SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharma Regal Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharma Regal Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharma Regal Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharma Regal Srl - CUI 22058275

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 207 153 682 516 356 250 146 0 0 0
Current Assets 81.979 72.952 68.974 70.297 56.582 95.776 29.887 14.762 8.651 5.049
Inventories 14.487 9.730 7.852 9.563 8.581 7.784 0 0 0 0
Receivables 55.482 51.226 55.001 53.071 41.623 65.278 15.387 4.391 4.709 3.756
Cash 12.010 11.997 6.120 7.664 6.378 22.714 14.500 10.371 3.942 1.293
Shareholders Funds 16.644 11.624 7.805 2.540 -4.204 42.255 24.516 9.391 3.298 -275
Social Capital 45 45 44 43 42 41 40 41 40 40
Debts 65.541 61.481 61.850 68.273 61.142 53.770 5.518 5.372 5.353 5.324
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 5.049 euro in 2024 which includes Inventories of 0 euro, Receivables of 3.756 euro and cash availability of 1.293 euro.
The company's Equity was valued at -275 euro, while total Liabilities amounted to 5.324 euro. Equity decreased by -3.554 euro, from 3.298 euro in 2023, to -275 in 2024.

Risk Reports Prices

Reviews - Pharma Regal Srl

Comments - Pharma Regal Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.